tiprankstipranks
Advertisement
Advertisement

CTSO Stock Latest News

Cytosorbents’ Earnings Call Balances Progress and Risk
Company AnnouncementsCytosorbents’ Earnings Call Balances Progress and Risk
6d ago
CTSO
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
PremiumRatings
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
7d ago
CTSO
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
PremiumCompany Announcements
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
7d ago
8K
CTSO
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
PremiumThe Fly
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
7d ago
CTSO
CTSO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CTSO Upcoming Earnings Report: What to Expect?
10d ago
CTSO
CytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
PremiumThe FlyCytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
3M ago
CTSO
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
Premium
The Fly
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
3M ago
CTSO
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
5M ago
CTSO
CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
PremiumThe Fly
CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
5M ago
CTSO
CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
PremiumCompany Announcements
CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
5M ago
CTSO
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
PremiumThe Fly
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
5M ago
CTSO
CytoSorbents implemented workforce and cost reduction program
PremiumThe Fly
CytoSorbents implemented workforce and cost reduction program
5M ago
CTSO
CTSO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCTSO Upcoming Earnings Report: What to Expect?
5M ago
CTSO
Cytosorbents Corp’s Latest Study Update: A Game Changer in Critical Care?
Premium
Company Announcements
Cytosorbents Corp’s Latest Study Update: A Game Changer in Critical Care?
5M ago
CTSO
CytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update
Premium
Company Announcements
CytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update
5M ago
CTSO
Cytosorbents Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Cytosorbents Faces Nasdaq Non-Compliance Notice
6M ago
8K
CTSO
CytoSorbents provides DrugSorb-ATR regulatory update
PremiumThe Fly
CytoSorbents provides DrugSorb-ATR regulatory update
7M ago
CTSO
CytoSorbents provides update of its appeal with FDA regarding DrugSorb-ATR
PremiumThe Fly
CytoSorbents provides update of its appeal with FDA regarding DrugSorb-ATR
7M ago
CTSO
Cytosorbents Corp Q2 2025 Earnings Call Highlights
PremiumCompany Announcements
Cytosorbents Corp Q2 2025 Earnings Call Highlights
8M ago
CTSO
Cytosorbents: Hold Rating Amid Regulatory Uncertainties and Revenue Shortfalls
PremiumRatingsCytosorbents: Hold Rating Amid Regulatory Uncertainties and Revenue Shortfalls
8M ago
CTSO
CytoSorbents Reports Positive Q2 2025 Financial Results
Premium
Company Announcements
CytoSorbents Reports Positive Q2 2025 Financial Results
8M ago
CTSO
CytoSorbents reports Q 2 adjusted EPS (5c) vs. (5c) last year
Premium
The Fly
CytoSorbents reports Q 2 adjusted EPS (5c) vs. (5c) last year
8M ago
CTSO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >